UNDERWEIGHT SPCX with 65-70% benchmark weight, $132 hard stop, $142 re-engagement trigger
UNDERWEIGHT SPCX at $139.63 with 65-70% benchmark weight allocation. The 7-session MACD histogram decay (+4.23 → +0.95) into the 50 SMA ($139.98) represents a rolling distribution pattern warranting position reduction. The $130 price target (60-90 day horizon) reflects the empty catalyst calendar through year-end 2026 and 87x forward P/E anchored to unaudited estimates. Institutional floor (Nvidia $21B 13F, Harvard $2.2B, D1, NBIM, Coatue, JPM, MS $300 PT) and audited 92% YoY revenue growth with 55.3% gross margin prevent escalation to a full Sell. Hard stop at $132 limits downside; $142 re-engagement trigger allows participation in any structural breakout. The path of least resistance is sideways-to-down until MACD histogram bottoms and price clears $142 on volume.
| Position | Action |
|---|---|
| Current levels ($139.50-140.00) | Sell 15-20% of position |
| Relief bounce into $141-143 (50/200 SMA cluster) | Sell 10-15% of position |
| Residual position cap | Cap at 65-70% of benchmark weight |
| Current levels ($139.50-140.00) | Do not initiate new long positions |
| First tactical target: $146 (Aug 12/17 swing high) | Trim position |
| $146 prints | Trail stops to 10 EMA ($137.17) |
| Second tactical target: $156.87 (Bollinger upper band) | Trim remaining position |
| Confirmed close above $142 on volume ≥60M | Scale back to neutral weight (95-100% benchmark) |
| Retest of $142 as support | Add to 110% benchmark |
| Close below $132 on volume >60M | Exit residual position |
SPCX is a generational infrastructure build with 92% YoY revenue growth, $93.5B cash, and a coiled-spring technical setup at the 50 SMA that offers asymmetric risk-reward with $300 Morgan Stanley PT upside vs. $95 bear case downside.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | 137.17 | bullish |
| 50 SMA | 139.98 | neutral |
| 200 SMA | 141.39 | bearish |
| 20 SMA (Bollinger Mid) | 131.45 | bullish |
| MACD | 2.09 (signal 1.14) | bullish |
| MACD Histogram | +0.95 (peaked +4.23 on 2026-08-17) | bearish |
| RSI | 53.52 | neutral |
| ATR(14) | 8.84 | neutral |
Support: 137.17 · 131.45 · 130 · 108.37 · 106.03 | Resistance: 139.98 · 141.39 · 146
SPCX technical analysis dated 2026-08-26 shows the stock at $139.63, recovering +29% from its July 31 trough of $108.37 but still -34% below its June 16 peak of $211.39. Short-term trend is bullish (price above rising 10 EMA at $137.17), but medium and long-term trends remain bearish as price sits just below the 50 SMA ($139.98) and 200 SMA ($141.39). MACD shows confirmed bullish crossover but momentum is fading (histogram declined from +4.23 peak on 08-17 to +0.95). RSI is neutral at 53.52 with mild bearish divergence noted. ATR compressed to 8.84 from a June peak of ~19.41. Key decision point: a close above $142 would confirm trend reversal; rejection at $140-141 with break below $135 would signal failed bounce.
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Confirmed close above $142 on volume ≥60M
Then: Scale to neutral (95-100% benchmark weight)
↩ rebuts: “Bear's interpretation of 'below 50 SMA' as bearish; 'fading MACD histogram' as red flag; 'fragile setup' framing”
EV: +$156 (first leg, Bollinger upper band); +$300 (Morgan Stanley PT, multi-year anchor) · concedes: Bear's timeline concern is valid — S-1 says 2028 for Nvidia orbital data centers vs. Musk's 2027; Valuation is stretched at 87x forward P/E (though hypergrowth warrants premium); MACD histogram is fading from +4.23 peak (deceleration is real, though trend remains intact); 200 SMA at $141.39 is a statistical artifact with only ~52 trading days of history
SPCX is a resistance rejection after momentum exhaustion, not a coiled spring—the stock crashed 49% in six weeks, is rejected by the 50 SMA, and is priced at 87x forward earnings on unaudited post-IPO estimates while burning $16.8B in quarterly FCF against $2.4B of operating cash flow.
· concedes: $93.5B in cash on balance sheet; 92% YoY revenue growth (though on a post-IPO distorted base); Morgan Stanley $300 price target; Coatue position as anchor investor; JPMorgan Overweight rating; TAM narrative of $28.5T (though TAM is not revenue)
→ vs conservative: Long-term thesis valid but doesn't protect against mid-cycle drawdowns of 50%+; Tesla spent 18 months below cash component before next leg; 50 SMA rejection with 7-session MACD decay and RSI divergence is not patience, it's negligence
→ vs conservative: $93.5B cash is runway shorter than burn rate implies when discounted for equity issuance dependency; if capital markets close (Starship failure, regulatory action, Musk controversy), burn rate becomes existential
→ vs neutral: Waiting for confirmation (break below $135 on volume) means stop at $134.50 triggers first; neutral discipline is a slower way to lose money; confirmation already in motion with MACD rolling and RSI diverging
→ vs neutral: The 'wait for confirmation' crowd already missed the rejection candle at $140; by the time breakdown is undeniable, they're selling at bottom of range instead of top
→ vs conservative: Buying at $139 because fundamentals are good is paying full price for a stock that just rejected its 50-day moving average; fundamentals were reason to buy at $108, not $139
Market Cap
$1,840,572,006,400 ($1.84T)
Share Price
~$139.66
52-Week High
$225.64
52-Week Low
$104.83
50-Day Avg
$141.04
200-Day Avg
$141.43
Forward P/E
87.19x
Price / Book
14.46x
EPS (TTM)
($1.10)
Forward EPS
$1.60
Book Value / Share
$9.66
Profit Margin (TTM)
-35.66%
Operating Margin (TTM)
-1.80%
Current Ratio
5.12
Debt to Equity
31.21
Revenue Q2'25
$4,071M
Revenue Q3'25
$4,067M
Revenue Q1'26
$4,694M
Revenue Q2'26
$7,814M
YoY Revenue Growth (Q2'26 vs Q2'25)
+92%
Gross Profit Q2'25
$1,789M
Gross Profit Q3'25
$2,105M
Gross Profit Q1'26
$2,306M
Gross Profit Q2'26
$4,319M
Gross Margin Q2'25
43.9%
Gross Margin Q3'25
51.8%
Gross Margin Q1'26
49.1%
Gross Margin Q2'26
55.3%
Operating Income Q2'25
($775M)
Operating Income Q3'25
$55M
Operating Income Q1'26
($1,943M)
Operating Income Q2'26
($141M)
EBITDA Q2'25
$1,068M
EBITDA Q3'25
$1,376M
EBITDA Q1'26
($1,164M)
EBITDA Q2'26
$2,959M
EBITDA TTM
$5.9B
Net Income Q2'25
($1,008M)
Net Income Q3'25
($528M)
Net Income Q1'26
($4,276M)
Net Income Q2'26
($541M)
Net Income TTM
($8.9B)
R&D Expense Q2'25
$1,958M
R&D Expense Q3'25
$1,557M
R&D Expense Q1'26
$3,514M
R&D Expense Q2'26
$3,548M
SG&A Q2'25
$606M
SG&A Q3'25
$493M
SG&A Q1'26
$746M
SG&A Q2'26
$912M
Revenue FY2023
$10,387M
Revenue FY2024
$14,015M
Revenue FY2025
$18,674M
YoY Growth FY2024
+35.0%
YoY Growth FY2025
+33.2%
TTM Revenue
$23.04B
Gross Profit FY2023
$4,277M
Gross Profit FY2024
$6,019M
Gross Profit FY2025
$9,223M
Gross Margin FY2023
41.2%
Gross Margin FY2024
42.9%
Gross Margin FY2025
49.4%
Operating Income FY2023
$507M
Operating Income FY2024
$742M
Operating Income FY2025
($2,064M)
Net Income FY2023
($4,628M)
Net Income FY2024
$791M
Net Income FY2025
($4,937M)
EBITDA FY2023
($663M)
EBITDA FY2024
$5,646M
EBITDA FY2025
$4,427M
Diluted EPS FY2023
($0.44)
Diluted EPS FY2024
$0.002
Diluted EPS FY2025
($0.51)
R&D FY2023
$2,105M
R&D FY2024
$3,464M
R&D FY2025
$8,643M
Cash & ST Investments Q1'26
$23,675M
Cash & ST Investments Q2'26
$100,009M
Cash & Equivalents Q2'26
$93.5B
Total Current Assets Q1'26
$29,732M
Total Current Assets Q2'26
$108,047M
Total Assets Q1'26
$102,094M
Total Assets Q2'26
$192,770M
Total Assets FY2024
$57,062M
Total Assets FY2025
$92,079M
Total Debt Q1'26
$30,603M
Total Debt Q2'26
$39,708M
Total Debt FY2024
$14,175M
Total Debt FY2025
$23,318M
Long-Term Debt Q1'26
$28,727M
Long-Term Debt Q2'26
$36,839M
Stockholders' Equity Q1'26
$41,582M
Stockholders' Equity Q2'26
$127,224M
Stockholders' Equity FY2024
$25,804M
Stockholders' Equity FY2025
$41,325M
Common Equity Q1'26
$34,533M
Common Equity Q2'26
$127,224M
Preferred Equity Q1'26
$7,049M
Preferred Equity Q2'26
$0
Tangible Book Value Q1'26
$20,146M
Tangible Book Value Q2'26
$113,184M
Working Capital Q1'26
$5,296M
Working Capital Q2'26
$86,925M
Goodwill & Intangibles FY2024
$15,085M
Goodwill & Intangibles FY2025
$14,983M
Net PP&E FY2024
$22,833M
Net PP&E FY2025
$43,862M
Net PP&E Q2'26
$66.9B
Operating Cash Flow Q2'25
($376M)
Operating Cash Flow Q3'25
$727M
Operating Cash Flow Q1'26
$1,047M
Operating Cash Flow Q2'26
$2,419M
Operating Cash Flow FY2023
$4,520M
Operating Cash Flow FY2024
$5,776M
Operating Cash Flow FY2025
$6,785M
Capex Q2'25
($2,847M)
Capex Q3'25
($4,140M)
Capex Q1'26
($10,114M)
Capex Q2'26
($19,238M)
Capex FY2023
($4,415M)
Capex FY2024
($11,163M)
Capex FY2025
($20,906M)
Free Cash Flow Q2'25
($3,223M)
Free Cash Flow Q3'25
($3,413M)
Free Cash Flow Q1'26
($9,067M)
Free Cash Flow Q2'26
($16,819M)
Free Cash Flow FY2023
$105M
Free Cash Flow FY2024
($5,387M)
Free Cash Flow FY2025
($14,121M)
Financing Cash Flow Q2'25
$8,845M
Financing Cash Flow Q3'25
$354M
Financing Cash Flow Q1'26
$7,125M
Financing Cash Flow Q2'26
$93,166M
Equity Issuance Q2'25
$4,148M
Equity Issuance Q3'25
$899M
Equity Issuance Q1'26
$8,319M
Equity Issuance Q2'26
$85,675M
Equity Issuance FY2023
$774M
Equity Issuance FY2024
$13,101M
Equity Issuance FY2025
$18,807M
Debt Issuance Q2'25
$6,199M
Debt Issuance Q3'25
$4,744M
Debt Issuance Q1'26
$22,694M
Debt Issuance Q2'26
$29,118M
Debt Issuance FY2023
$0
Debt Issuance FY2024
$0
Debt Issuance FY2025
$16,055M
Stock-Based Comp FY2023
$679M
Stock-Based Comp FY2024
$784M
Stock-Based Comp FY2025
$1,947M
End Cash Q2'25
$15,094M
End Cash Q3'25
$8,482M
End Cash Q1'26
$16,608M
End Cash Q2'26
$94,352M
Net Cash Position
~$54B
Shares Outstanding
13.18B
Diluted Avg Shares Q2'26
5.86B
Strengths
Concerns
SPCX demonstrated exceptional fundamental performance in Q2 2026 with revenue of $7.8B (+92% YoY) and gross margin expansion to 55.3%, driven by Starlink subscriber growth and increased launch cadence. The company maintains a fortress balance sheet with $93.5B in cash following a ~$85.7B equity injection from its 2026 IPO, providing multi-year runway for Starship and Starlink capex despite negative FCF of $16.8B in Q2 2026. The analyst rates SPCX as a high-conviction long-term HOLD given stretched 87x forward P/E valuation, persistent GAAP losses driven by non-cash charges and heavy R&D ($3.5B/quarter), and execution risks on Starship commercial ramp — while acknowledging the company's dominant market position and secular space economy tailwinds.
Macro: Higher-for-longer rate regime is the base case with very low recession odds (8% implied by end-2026). Fed cut probabilities: 1% by Sept 2026 FOMC, 5% by Oct 2026, 12% by Dec 2026. No near-term Fed cuts priced in. PCE inflation ticked up this week, reinforcing the hawkish stance. Soft-landing base case dominant—this is mildly positive for SPCX as growth-asset multiples aren't being compressed by imminent easing, but also means no 'Fed pivot' tailwind. SPCX must earn its multiple through execution. Commodity/copper strength (ICOP ETF at 52-week high) signals continued industrial demand, broadly supportive of A&D capex.